| Website | spinomix.com |
| Category | BioTech |
| Phone | +41 21 693 92 50 |
| contact@spinomix.com | |
| Employees |
| TOTAL | $3M |
| FUNDING TOTAL | $3M |
| Series A, 1/13 Debiopharm Group | $3M |
Spinomix SA is a spin-off company of the Swiss Federal Institute of Technology of Lausanne (EPFL) founded in November 2004. Our technology platform is based on a proprietary magnetic nanoparticles handling technology (MagPhase) in microfluidic environment (lab-on-chip). This technology offers cost efficient, reliable fully automated and miniaturized systems for various applications in life-science and in-vitro diagnostics.
